Weight Watchers is an organisation that seeks to have a positive impact on the lives of people every day. Our support of Innovation Nation provides a unique method of positively supporting and investing in young people to build a brighter future for themselves in Australia.
Weight Watchers International, Inc. is the world’s leading commercial provider of weight management services, operating globally through a network of Company-owned and franchise operations. Weight Watchers holds more than 32,000 meetings each week where members receive group support and learn about healthy eating patterns, behavior modification and physical activity. Weight Watchers provides innovative, digital weight management products through its websites, mobile sites and apps. Weight Watchers is the leading provider of paid digital subscription weight management products in the world. In addition, Weight Watchers offers a wide range of products, publications and programs for those interested in weight loss and weight control.
We know that backing young people – encouraging them to live life to the fullest – provides an invaluable platform to grow and learn in an immersive environment. Supporting the Innovation Nation is an outstanding opportunity to invest in young people who are focused on creating social change within Australia.
Abbott Vascular, a division of Abbott Laboratories, is a global leader in cardiac and vascular care with market leading products and an industry leading pipeline. We are committed to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education.
We offer cutting-edge devices for coronary artery disease, peripheral vascular disease and structural heart disease. Our flagship product is the market-leading XIENCE family of drug eluting stents, for the treatment of coronary artery disease. In addition, we offer, Absorb, the first Bioresorbable Vascular Scaffold, defining a new paradigm of vascular reparative therapy, and the MitraClip Percutaneous Mitral Valve Repair System, expanding treatment options for patients suffering from the debilitating symptoms of mitral regurgitation.
Charter Hall Group (ASX:CHC) is one of Australia’s leading fully integrated property groups, with over 25 years’ experience owning, developing and managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall has over $17 billion of funds under management across the office, retail and industrial sectors.
The Group’s success is underpinned by a highly skilled and motivated team who operate in over 100 communities around Australia. Community investment is integrated into our business approach, ensuring our actions are commercially sound and make a difference to our people, customers and the environment.
Charter Hall is proud to partner with Innovation Nation, as it provides an opportunity to invest in the young Australian’s in our communities across Australia, who are the innovators and entrepreneurs of the future.